VNA
IBB icon

Valley National Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Valley National Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Hold
2,621
– – 0.06% 179
2026
Q1 		$442K Sell
2,621
-9
-0.3% -$1.54K 0.06% 183
2025
Q4 		$443K Buy
2,630
+109
+4% +$17.7K 0.06% 183
2025
Q3 		$363K Sell
2,521
-730
-22% -$99.6K 0.06% 190
2025
Q2 		$411K Sell
3,251
-138
-4% -$16.9K 0.07% 176
2025
Q1 		$433K Sell
3,389
-793
-19% -$108K 0.08% 169
2024
Q4 		$552K Buy
4,182
+394
+10% +$55.4K 0.1% 155
2024
Q3 		$551K Sell
3,788
-41
-1% -$5.93K 0.1% 157
2024
Q2 		$525K Sell
3,829
-1,299
-25% -$173K 0.08% 155
2024
Q1 		$703K Sell
5,128
-226
-4% -$30.9K 0.11% 137
2023
Q4 		$727K Buy
5,354
+449
+9% +$54.8K 0.12% 134
2023
Q3 		$600K Hold
4,905
– – 0.1% 139
2023
Q2 		$623K Sell
4,905
-284
-5% -$36.9K 0.1% 146
2023
Q1 		$690K Sell
5,189
-57
-1% -$7.46K 0.12% 140
2022
Q4 		$702K Sell
5,246
-219
-4% -$28.3K 0.13% 133
2022
Q3 		$671K Buy
5,465
+1,249
+30% +$155K 0.14% 129
2022
Q2 		$530K Hold
4,216
– – 0.11% 154
2022
Q1 		$549K Sell
4,216
-220
-5% -$28.7K 0.11% 162
2021
Q4 		$677K Sell
4,436
-216
-5% -$33.4K 0.12% 144
2021
Q3 		$752K Sell
4,652
-84
-2% -$14.1K 0.14% 131
2021
Q2 		$775K Buy
4,736
+125
+3% +$19.3K 0.14% 128
2021
Q1 		$694K Sell
4,611
-189
-4% -$30K 0.14% 129
2020
Q4 		$727K Sell
4,800
-234
-5% -$33.4K 0.15% 118
2020
Q3 		$682K Sell
5,034
-342
-6% -$46.4K 0.16% 99
2020
Q2 		$735K Buy
5,376
+254
+5% +$32.4K 0.17% 93
2020
Q1 		$552K Sell
5,122
-122
-2% -$14K 0.15% 107
2019
Q4 		$632K Sell
5,244
-120
-2% -$13.4K 0.16% 111
2019
Q3 		$534K Sell
5,364
-620
-10% -$64.9K 0.15% 111
2019
Q2 		$653K Sell
5,984
-391
-6% -$41.6K 0.18% 97
2019
Q1 		$713K Sell
6,375
-661
-9% -$72.5K 0.2% 91
2018
Q4 		$678K Buy
7,036
+419
+6% +$44.5K 0.22% 89
2018
Q3 		$807K Sell
6,617
-45
-0.7% -$5.3K 0.28% 79
2018
Q2 		$732K Sell
6,662
-15
-0.2% -$1.6K 0.28% 80
2018
Q1 		$713K Hold
6,677
– – 0.27% 78
2017
Q4 		$713K Buy
6,677
+509
+8% +$54.4K 0.25% 78
2017
Q3 		$686K Sell
6,168
-81
-1% -$8.66K 0.23% 75
2017
Q2 		$646K Sell
6,249
-354
-5% -$34.9K 0.23% 76
2017
Q1 		$646K Sell
6,603
-1,512
-19% -$145K 0.25% 74
2016
Q4 		$718K Sell
8,115
-1,203
-13% -$109K 0.33% 78
2016
Q3 		$899K Sell
9,318
-276
-3% -$26.3K 0.46% 63
2016
Q2 		$823K Sell
9,594
-1,302
-12% -$117K 0.43% 68
2016
Q1 		$947K Buy
10,896
+1,575
+17% +$141K 0.51% 60
2015
Q4 		$1.05M Buy
9,321
+474
+5% +$51.4K 0.62% 52
2015
Q3 		$895K Buy
8,847
+372
+4% +$44.6K 0.54% 58
2015
Q2 		$1.04M Sell
8,475
-5,193
-38% -$622K 0.59% 54
2015
Q1 		$1.56M Buy
13,668
+3,699
+37% +$408K 0.92% 34
2014
Q4 		$755K Buy
+9,969
New +$969K 0.57% 49

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Valley National Advisers's IBB Position: Q2 2026 in Review

Valley National Advisers held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,621 shares worth $498K. The position accounts for 0.06% of the portfolio, ranked #179.

Valley National Advisers first reported a position in IBB in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.56M in Q1 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Valley National Advisers held 2,621 shares of iShares Biotechnology ETF worth $498K as of Q2 2026.
  • Valley National Advisers left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.06% of Valley National Advisers's portfolio in Q2 2026, its #179 holding.
  • Valley National Advisers first reported a position in iShares Biotechnology ETF in Q4 2014 and has held it in 47 quarters since.
  • Valley National Advisers's iShares Biotechnology ETF position peaked at $1.56M in Q1 2015.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.